Acrylamide (AA) is an important industrial chemical used mainly in the production of polymers. It can be absorbed through the skin. AA was shown to be a germ cell clastogen that entails a genetic risk for exposed workers. The genetic risk calculation was based on mouse heritable translocation test data obtained after acute intraperitoneal (ip) exposure (Adler et al., 1994). To obtain a correction factor between ip and dermal exposure, dominant lethal and heritable translocation tests were carried out with dermal exposure of male mice to AA. In the dominant lethal test, male (102/El × C3H/El)F1 mice were exposed by dermal application to the shaved backs of 50 mg/kg AA per day on five consecutive days or to five daily ip injections of 50 mg/kg AA. One day after the end of exposure, the males were mated to untreated females of the same hybrid stock for four days and females were changed every four days for a total of five matings. Dominant lethal effects were found during matings 1–3. For ip exposure, these values were 81.7, 85.7 and 45.4%, respectively; for dermal exposure the corresponding values were 22.1, 30.6 and 16.5%, respectively. In the heritable translocation assay, male C3H/El mice were treated with five dermal exposures of 50 mg/kg AA and mated 1.5–8.5 days after the end of exposure to untreated female 102/El mice. Pregnant females were allowed to come to term and all offspring were raised to maturity. Translocation carriers among the F1 progeny were selected by a sequential fertility testing and cytogenetic analysis including G-band karyotyping and M-FISH. A total of 475 offspring were screened and 41 translocation carriers were identified. The observed translocation frequency after dermal exposure was 8.6% as compared to 21.9% after similar ip exposure (Adler, 1990). The calculated ratio of ip vs. dermal exposure of 0.39 can be applied to obtain a more realistic calculation of genetic risk for dermally exposed workers.   

1.
Abramsson-Zetterberg L: The dose-response relationship at very low doses of acrylamide is linear in the flow cytometer based mouse micronucleus assay. Mutat Res 535:215–222 (2003).
2.
Adler I-D: Clastogenic effects of acrylamide in different germ-cell stages of male mice. Banbury Report 34: Biology of Mammalian Germ Cell Mutagenesis, pp 115–131 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor 1990).
3.
Adler I-D, Ingwersen I, Kliesch U, El Tarras A: Clastogenic effects of acrylamide in mouse bone marrow cells. Mutat Res 206:379–385 (1988).
4.
Adler I-D, Reitmeir P, Schmöller R, Schriever-Schwemmer G: Dose response for heritable translocations induced by acrylamide in spermatids of mice. Mutat Res 309:285–291 (1994).
5.
Adler I-D, Baumgartner A, Gonda H, Friedman MA, Skerhut M: 1-Aminobenzotriazole inhibits acrylamide-induced dominant lethal effects in spermatids of male mice. Mutagenesis 15:133–136 (2000).
6.
Adler I-D, Kliesch U, Jentsch I, Speicher MR: Induction of chromosomal aberrations by dacarbazine in somatic and germinal cells of mice. Mutagenesis 17:383–389 (2002).
7.
Bull RJ, Robinson M, Laurie RD, Stober GD, Geisinger E, Meier JR, Stober J: Carcinogenic effects of acrylamide in Sencar and A/J mice. Cancer Res 44:107–111 (1984).
8.
Carlson GP, Weaver PM: Distribution and binding of [14C] acrylamide to macromolecules in SENCAR and BALB/c mice following oral and topical administration. Toxicol Appl Pharmacol 79:307–313 (1985).
9.
Dearfield KL, Abernathy CO, Ottley MS, Brantner JH, Hayes PF: Acrylamide: its metabolism, developmental and reproductive effects, genotoxicity and carcinogenicity. Mutat Res 195:45–77 (1988).
10.
O’Donoghue JL: Acrylamide and related substances, in O’Donoghue JL (ed): Neurotoxicity of Industrial and Commercial Chemicals, Vol II, pp 169–177 (CRC Press, Boca Raton 1985).
11.
Ehling UH, Neuhäuser-Klaus A: Re-evaluation of the induction of specific-locus mutations in spermatogonia of the mouse by acrylamide (AA). Mutat Res 283:185–191 (1992).
12.
Evans EP: Standard normal chromosomes, in Lyon MF, Searle AG (eds): Genetic Variants and Strains of the Laboratory Mouse, pp 576–581 (Oxford University Press, Oxford 1989).
13.
Evans EP, Breckon G, Ford CE: An air-drying method for meiotic preparation from mammalian testis. Cytogenetics 3:289–294 (1964).
14.
Gallimore PH, Richardson CR: An improved banding technique exemplified in the karyotype analysis of two strains of rat. Chromosoma 41:259–263 (1973).
15.
Gutierrez-Espeleta GA, Highes LA, Piegorsch WW, Shelby MD, Generoso WM: Acrylamide: dermal exposure produces genetic damage in male mouse germ cells. Fundam Appl Toxicol 18:189–192 (1992).
16.
Hashimoto K, Tanii H: Mutagenicity of acrylamide and its analogues in Salmonella typhimurium. Mutat Res 158:129–133 (1985).
17.
Holland N, Ahlborn T, Turteltaub K, Markee C, Moore II D, Wyrobek AJ, Smith MT: Acrylamide causes preimplantation abnormalities in embryos and induces chromatin adducts in male germ cells of mice. Repro Tox 13:167–178 (1999).
18.
Jentsch A, Adler I-D, Carter N, Speicher MR: Karyotyping of mouse chromosomes by multiplex-FISH (M-FISH). Chrom Res 9:21–24 (2001).
19.
Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CH, Friedman MA, Mast RW: Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154–168 (1986).
20.
Knaap AGAC, Kramers PGN, Voogd CE, Bergkamp WGM, Groot MG, Langebroek PG, Mout HCA, van der Stel J, Verharen HW: Mutagenic activity of acrylamide in eukaryotic systems but not in bacteria. Mutagenesis 3:263–268 (1988).
21.
Lijinsky W, Andrews A: Mutagenicity of vinyl compounds in Samonella typhimurium. Teratogen Carcinogen Mutagen 1:259–267 (1980).
22.
Marchetti F, Lowe X, Bishop J, Wyrobek AJ: Induction of chromosomal aberrations in mouse zygotes by acrylamide treatment of male germ cells and their correlation with dominant lethality and heritable translocations. Environ Mol Mutagenesis 30:410–417 (1997).
23.
Miller MS, Spencer PS: The mechanisms of acrylamide axonopathy. A Rev Pharmacol Toxicol 25:643–666 (1985).
24.
Moore MM, Amtower A, Doerr C, Brock KH, Dearfield KL: Mutagenicity and clastogenicity of acrylamide in L5178Y mouse lymphoma cells. Environ Mutagen 9:261–267 (1987).
25.
Pacchierotti F, Tiveron C, D’Archivio M, Bassani B, Cordelli E, Leter G, Spano M: Acrylamide-induced chromosomal damage in male mouse germ cells detected by cytogenetic analysis of one-cell zygotes. Mutat Res 309:273–284 (1994).
26.
Paulsson B, Kotova N, Grawé J, Henderson A, Granath F, Golding B, Törnqvist M: Induction of micronuclei in mouse and rat by glycidamide, genotoxic metabolite of acrylamide. Mutat Res 535:15–24 (2003).
27.
Russell LB, Hunsicker PR, Cacheiro NLA, Generoso WM: Induction of specific-locus mutations in male germ cells of the mouse by acrylamide monomer. Mutat Res 262:101–107 (1991).
28.
Sega GA, Alcota RPV, Tancongco CP, Brimer PA: Acrylamide binding to DNA and protamine of spermatogenic stages in the mouse and its relationship to genetic damage. Mutat Res 216:221–230 (1989).
29.
Shelby MD, Cain KT, Hughes LA, Braden PW, Generoso WM: Dominant lethal effects of acrylamide in male mice. Mutat Res 173:35–40 (1986).
30.
Shelby MD, Cain KT, Cornett CV, Generoso WM: Acrylamide: induction of heritable translocations in male mice. Environ Mutagen 9:363–368 (1987).
31.
Shiraishi Y: Chromosome aberrations induced by monomeric acrylamide in bone marrow and germ cells of mice. Mutat Res 57:313–324 (1978).
32.
Smith MK, Zenick H, Preston RJ, George EL, Long RE: Dominant lethal effects of subchronic acrylamide administration in the male Long-Evans rat. Mutat Res 173:273–277 (1986).
33.
Tareke E, Rydberg P, Karlsson S, Törnqvist M: Acrylamide: a cooking carcinogen? Chem Res Toxicol 13:517–522 (2000).
34.
Tareke E, Rydberg P, Karlsson S, Eriksson S, Törnqvist M: Analysis of acrylamide, a carcinogen formed in heated foodstuff. J Agric Food Chem 50:4998–5006 (2002).
35.
Tilson HA: The neurotoxicity of acrylamide: an overview. Neurobehav Toxicol Teratol 3:445–461 (1981).
36.
Tyl RW, Friedman MA: Effects of acrylamide on rodent reproductive performance. Reprod Toxicol 17:1–13 (2003).
37.
Witt KL, Hughes LA, Burka LT, McFee AF, Mathews JM, Black SL, Bishop JB: Mouse bone marrow micronucleus test results do not predict the germ cell mutagenicity of N-hydroxymethylacrylamide in the mouse dominant lethal assay. Environ Mol Mutagenesis 41:111–120 (2003).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.